When we say that our eyesight is 1.0 and 0.8 we often express the degree of function that depends on the function of this ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think ...

What is macular degeneration? There is a structure called the retina in the back of our eyes that acts like film, capturing ...

Practice-changing studies in dry age-related macular degeneration (AMD) and promising new directions in wet AMD, presented at ...

The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...

The investigators explained that AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions. 2 ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think ...

Worldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as “exudative ...

The ELEVATUM study is designed to investigate how faricimab impacts DME in Black Americans. By enrolling, you'll contribute ...

A study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet ...

A blind veteran from Hampshire will be one of many people remembering the fallen at war memorials this Remembrance Sunday.

Neurotech Pharmaceuticals, Inc., an innovator in sustained drug delivery for chronic retinal diseases, today announced that the U.S. Food and Drug Administration (FDA), has extended the Prescription ...